Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
7.65
Nov 17 • 3:59 PM ET Dollar change-0.12 Percentage change(-1.54%)
Aftermarket Close
7.71
Aftermarket • 5:51 PM ET Dollar change+0.06 Percentage change(0.78%)
Index
RUT
Market Cap
481.21M
Enterprise Value
491.64M
Income
-15.97M
Sales
45.95M
Book/sh
1.11
Cash/sh
0.26
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
158
IPO
Jun 25, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
10.47
P/B
6.87
P/C
29.06
P/FCF
-
EV/EBITDA
-
EV/Sales
10.70
Quick Ratio
2.72
Current Ratio
3.56
Debt/Eq
0.45
LT Debt/Eq
0.42
Option/Short
Yes / Yes
EPS (ttm)
-0.30
EPS next Y
-0.22
EPS next Q
-0.08
EPS this Y
12.22%
EPS next Y
23.00%
EPS next 5Y
17.70%
EPS past 3/5Y
42.42% -
Sales past 3/5Y
-0.73% 5.30%
EPS Y/Y TTM
12.64%
Sales Y/Y TTM
15.45%
EPS Q/Q
18.85%
Sales Q/Q
21.52%
Insider Own
79.65%
Insider Trans
0.00%
Inst Own
15.11%
Inst Trans
0.07%
ROA
-15.79%
ROE
-24.12%
ROIC
-18.84%
Gross Margin
33.93%
Oper. Margin
-31.60%
Profit Margin
-34.76%
SMA20
1.55%
SMA50
-3.00%
SMA200
47.84%
Trades
Shs Outstand
53.70M
Shs Float
12.80M
52W High
9.48 -19.30%
52W Low
1.91 300.52%
Volatility
7.30% 9.80%
ATR (14)
0.64
RSI (14)
48.06
Beta
0.95
Rel Volume
0.39
Avg Volume
442.00K
Volume
171,779
Perf Week
-12.37%
Perf Month
12.50%
Perf Quarter
6.10%
Perf Half Y
105.65%
Perf YTD
101.32%
Perf Year
78.74%
Perf 3Y
273.17%
Perf 5Y
-69.52%
Perf 10Y
-
Prev Close
7.77
Price
7.65
Change %
-1.54%
Consensus
Strong Buy
Avg. Price Target
$9.83
Implied Upside
+28.5%
Analysts5incl. previous ratings
Rating Distribution5 Buy · 0 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Sep 17, 2026Initiated
JEF logoJJefferies
Buy$9+17.6%
Aug 11, 2026Upgrade
BBTIG Research
Neutral → Buy$8+4.6%
Aug 05, 2026Initiated
RRoth Capital
Buy$7-8.5%
Jul 22, 2025Resumed
SStephens
Overweight$8+4.6%
Feb 10, 2025Initiated
CCraig Hallum
Buy$12+56.9%
Mar 12, 2024Downgrade
BBTIG Research
Buy → Neutral
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lowell MatthewChief Financial OfficerMar 06 '26Buy2.1940,00087,616168,376Mar 09 04:30 PM
Gunstream StephenPresident and CEOMar 06 '26Buy2.1526,00055,801269,497Mar 09 04:24 PM
Alpha Teknova, Inc. engages in the manufacture of cell culture media and supplements. It provides reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. The company was founded by Thomas E. Davis in 1996 and is headquartered in Hollister, CA.
PresidentMr. Stephen Gunstream
Chief Financial OfficerMr. Matthew C. Lowell
General CounselMr. Damon A. Terrill J.D.
Senior Vice President of MarketingMs. Jennifer Henry